Day: April 6, 2020

MORRIS PLAINS, N.J., April 06, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that its Board of Directors (Board) has appointed Harout Semerjian as President and Chief Executive Officer (CEO) and as a member of the Board, effective April 16, 2020.Commenting on this appointment, Dr. Behzad Aghazadeh, Executive Chairman of the Board, stated, “I am delighted that Harout has agreed to join us at this critical juncture in the evolution of Immunomedics. He is a seasoned global pharmaceutical leader with a passion for and expertise in oncology. His long and successful track record in leading cross functional teams and delivering on ambitious results will be instrumental in scaling the Company and its...

NEW YORK, April 06, 2020 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (“PNNT,” “we” or “our”) (Nasdaq: PNNT) announced today that it issued an open letter to its stakeholders regarding a business update amid the COVID-19 pandemic.The full text of the letter follows:Dear Stakeholders:We felt it important to provide an update on PennantPark Investment Corporation (“PNNT,” “we,” “us” or “our”) in light of the massive economic and capital markets disruptions caused by COVID-19.  First and foremost, we hope that you are safe and healthy in these difficult times.  Fortunately, our entire PennantPark team is safe and healthy and has been successfully working remotely from home for the past three weeks.  Our contingency planning has functioned effectively and as intended. As a result, the transition of our entire team to remote...

NEW YORK, April 06, 2020 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (the “Company”) (NASDAQ: PFLT) (TASE: PFLT) announced today that it issued an open letter to its stakeholders regarding a business update amid the COVID-19 pandemic.The full text of the letter follows:Dear Stakeholders:We felt it important to provide an update on PennantPark Floating Rate Capital Ltd. (“PFLT,” “we,” “us” or “our”) in light of the massive economic and capital markets disruptions caused by COVID-19.  First and foremost, we hope that you are safe and healthy in these difficult times. Fortunately, our entire PennantPark team is safe and healthy and has been successfully working remotely from home for the past three weeks. Our contingency planning has functioned effectively and as intended. As a result, the transition of our entire team...

FORT COLLINS, Colo., April 06, 2020 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ: WWD) today announced a series of immediate initiatives to address the economic challenges resulting from the coronavirus (COVID-19) pandemic, which Woodward believes will result in an extended period of uncertainty.Thomas A. Gendron, Chairman, Chief Executive Officer and President, said, “With the rapid spread of the coronavirus, we are living in unprecedented times, and I want to recognize the hard work and commitment of our employees as we work together to support one another in this challenging environment. As we navigate through the economic disruption caused by this pandemic, we are highly focused on ensuring the safety and well-being of our employees while protecting our business, maintaining our strong position with our customers and suppliers,...

TORONTO, April 06, 2020 (GLOBE NEWSWIRE) — Gowest Gold Ltd. (“Gowest” or the “Company”) (TSX VENTURE: GWA) announced today that it has entered into a bridge loan agreement (the “Agreement”) with Lush Land Investment Canada Inc. (“Lush Land”) for a loan facility of up to C$1.6 million. The Company has received the first $1.0 million under the Agreement, and the balance is expected to be advanced before the end of the month.The purpose of the Agreement is to enable Gowest to continue to move ahead with its Advanced Exploration Bulk Sample program at the Company’s 100% owned Bradshaw Gold Deposit (“Bradshaw”) while the Company continues to work towards a significantly larger financing. Gowest has started initial discussions with interested parties regarding one or more financings to raise sufficient funds to complete the bulk sample...

WASHINGTON, April 06, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that the Company has been named to Forbes magazine’s list of America’s Best Management Consulting Firms, recognized in 14 sectors and functional areas.Commenting on the recognition, Steven H. Gunby, President and Chief Executive Officer of FTI Consulting, said, “Being recognized on the Forbes list of America’s Best Management Consulting Firms for the fifth consecutive year is a gratifying reflection of the success we are having in supporting terrific professionals as they leverage our global expertise to help clients with their most significant challenges and opportunities.”FTI Consulting was recognized in the following sectors and functional areas:AutomotiveConstruction & InfrastructureFinance & Risk ManagementFinancial InstitutionsInternet,...

VANCOUVER, British Columbia, April 06, 2020 (GLOBE NEWSWIRE) — Balmoral Resources Ltd. (“Balmoral” or the “Company”) (TSX:BAR; OTCQX:BALMF) announced today that it has mailed and filed its management information circular (the “Circular”) and related meeting materials in connection with a special meeting (the “Meeting”) of the holders of common shares (the “Balmoral Common Shares”, such holders of Balmoral Common Shares, the “Balmoral Shareholders”), stock options and deferred share units of the Company (together with the Balmoral Common Shares, the “Balmoral Securities”, such holders of the Balmoral Securities, the “Balmoral Securityholders”) to be held on May 7, 2020. The purpose of the Meeting is to seek the Balmoral Securityholders’ approval in connection with the previously announced (see NR20-04, March 2, 2020) proposed acquisition...

TORONTO, April 06, 2020 (GLOBE NEWSWIRE) — Sprott Resource Holdings Inc. (“SRHI” or the “Company”) (TSX: SRHI) today announced that it has received written notice from the lenders of Minera Tres Valles SpA (“MTV”), the Company’s 70% Chilean copper mining subsidiary, that certain events of default have occurred and are continuing under the loan facility agreement (the “Agreement”) with MTV including (but not limited to) events of default under clauses 24.6 (Insolvency), 24.12 (Expropriation and Export Restrictions) and/or 24.14 (Material Adverse Effects).The lenders have informed MTV and the Company that it has chosen not to exercise its rights and remedies under the Agreement at this time as a consequence of these events of default, but may choose to do so at any time in the future without any further written notice.The Company,...

VANCOUVER, British Columbia, April 06, 2020 (GLOBE NEWSWIRE) — FPX Nickel Corp. (FPX-TSX.V) (“FPX Nickel” or the “Company”) is pleased to provide an update on its corporate activities, including its plans for the preparation of an updated National Instrument (“NI”) 43-101 preliminary economic assessment (“PEA”) report on the Company’s Baptiste Deposit at its 100%-owned Decar Nickel District in central British Columbia.  As previously disclosed in its news release dated February 25, 2020, the Company anticipates completion of the PEA in the late third quarter or fourth quarter of 2020.FPX Nickel continues to monitor the outbreak of COVID-19 and the health and safety of its employees and consultants, who are being encouraged to work from home, where possible.  The Company has access to all field and laboratory data which it requires...

WAKEFIELD, Mass., April 06, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB: IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today the Company is engaged in discussions with health care provider networks and hospitals both in the United States and Europe regarding options to rapidly advance Brilacidin testing into human trials to evaluate its potential as a novel coronavirus (COVID-19) therapeutic.Their interest in Brilacidin as a treatment for COVID-19 and associated complications is based on the drug’s promising antiviral activity against SARS-CoV-2, as supported in preliminary testing conducted in a monkey epithelial cell line and its established anti-inflammatory and antimicrobial properties—a potential 3-in-1 treatment combination. In advance of potential clinical testing, the Company is...